Intermittent hypoxic training as a rehabilitation method for patients with cardiovascular diseases: a review

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Ensuring the full restoration of the body’s functional capacity is a primary goal of medical rehabilitation. The introduction of new rehabilitation methods into clinical practice makes it possible to achieve substantial progress in the treatment and prevention of diseases. This may be associated with greater effectiveness of specific techniques, simplicity and safety of their application (which improves patient adherence), and their economic accessibility. In recent years, increasing interest has been directed toward the effects of intermittent hypoxia on the human body. The mechanisms underlying the clinically substantial effects of intermittent hypoxic training have been described at various levels, ranging from the regulation of gene expression to systemic physiological responses.

Intermittent hypoxic training is a method that has found application in the prevention and treatment of a number of chronic non-communicable diseases of the cardiovascular, respiratory, and nervous systems, as well as endocrine disorders, and it also affects inflammatory and aging-related processes. Intermittent hypoxic training can be applied both at rest and during physical exercise, which enables its use in sports medicine. Over the past decade, a technique alternating periods of hypoxia and hyperoxia has been actively developed. It has been suggested that replacing normoxic periods with hyperoxic ones may increase the effectiveness of intermittent hypoxic training and reduce adverse side effects.

This article presents a review of data from Russian and international scientific data concerning the mechanisms of action of intermittent hypoxic training on the human body and the possibilities of its use in cardiovascular condition.

Full Text

Restricted Access

About the authors

Aleksandr K. Nagovitsin

Voronezh State Medical University

Author for correspondence.
Email: nagovizinak@gmail.com
ORCID iD: 0000-0002-2452-1105
SPIN-code: 3024-7503
Russian Federation, Voronezh

Yuliya A. Kotova

Voronezh State Medical University

Email: kotova_u@inbox.ru
ORCID iD: 0000-0003-0236-2411
SPIN-code: 8518-0355

MD, Dr. Sci. (Medicine), Assistant Professor

Russian Federation, Voronezh

References

  1. Aronov DM, Bubnova MG, Drapkina OM. Non-pharmacological therapy of patients with cardiovascular diseases in cardiac rehabilitation programs. Profilakticheskaya meditsina. 2020;23(6-2):57–64. doi: 10.17116/profmed20202306257 EDN: BRBEUT
  2. Hansen D, Abreu A, Ambrosetti M, et al. Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2022;29(1):230–245. doi: 10.1093/eurjpc/zwad397
  3. Ambrosetti M, Abreu A, Corrà U, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2021;28(5):460–495. doi: 10.1177/2047487320913379 EDN: XKWALS
  4. Doimo S, Fabris E, Piepoli M, et al. Impact of ambulatory cardiac rehabilitation on cardiovascular outcomes: a long-term follow-up study. Eur Heart J. 2019;40:678–685. doi: 10.1093/eurheartj/ehy417 EDN: NXYVOK
  5. Burtscher M, Gatterer H, Szubski C, Pierantozzi E, Faulhaber M. Effects of interval hypoxia on exercise tolerance: special focus on patients with CAD or COPD. Sleep Breath. 2010;14(3):209–220. doi: 10.1007/s11325-009-0289-8 EDN: OLPZSB
  6. Glazachev OS, Zvenigorodskaja LA, Dudnik EN, et al. Interval hypo-hyperoxic training in the treatment of metabolic syndrome. Experimental and clinical gastroenterology journal. 2010;(7):51–56. EDN: MVAJUH
  7. Glazachev OS, Pozdnyakov YuM, Urinskyi AM, Zabashta SP. Hypoxia-hyperoxia adaptation and increased exercise capacity in patients with coronary heart disease. Cardiovascular Therapy and Prevention. 2014;13(1):16–21. doi: 10.15829/1728-8800-2014-1-16-21 EDN: RZDWHZ
  8. Glazachev OS. Optimization of Clinical Application of Interval Hypoxic Training. Biomedical engineering. 2013;3(279)):21–24. EDN: QBMKPF
  9. Zagaĭnaia E, Kopylov FIu, Glazachev OS, et al. Effect of interval hypoxic-hypoxic training on exercise tolerance in patients with angina pectoris functional classes II—III on background of optimal medical therapy. Russian Journal of Cardiology and Cardiovascular Surgery. 2015;8(3):33–38. doi: 10.17116/kardio20158333-38 EDN: ULFCOR
  10. Lyamina NP, Lyamina SV, Skorobogatyth NV, Ksenofontova IV, Spirina GK. Controlled hypoxia-hyperoxytherapy as a component of a targeted approach in the rehabilitation of patients with multimorbidity: a single-center, randomized, placebo-controlled, prospective study. Physical and rehabilitation medicine, medical rehabilitation. 2023;5(4):279–288. doi: 10.36425/rehab608182 EDN: YOGGRY
  11. Tessema B, Sack U, König B, Serebrovska Z, Egorov E. Effects of Intermittent Hypoxia in Training Regimes and in Obstructive Sleep Apnea on Aging Biomarkers and Age-Related Diseases: A Systematic Review. Front Aging Neurosci. 2022;14:878278. doi: 10.3389/fnagi.2022.878278 EDN: BYSJPV
  12. Semenza GL. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol. 2014;9:47–71. doi: 10.1146/annurev-pathol-012513-104720 EDN: UVKZFN
  13. Antikainen H, Driscoll M, Haspel G, Dobrowolski R. TOR-mediated regulation of metabolism in aging. Aging Cell. 2017;16(6):1219–1233. doi: 10.1111/acel.12689
  14. Hong S, Zhao B, Lombard DB, Fingar DC, Inoki K. Cross-talk between sirtuin and mammalian target of rapamycin complex 1 (mTORC1) signaling in the regulation of S6 kinase 1 (S6K1) phosphorylation. J Biol Chem. 2014;289(19):13132–13141. doi: 10.1074/jbc.M113.520734 EDN: YEXDXH
  15. Pan H, Finkel T. Key proteins and pathways that regulate lifespan. J Biol Chem. 2017;292(16):6452–6460. doi: 10.1074/jbc.R116.771915
  16. Ruderman NB, Xu XJ, Nelson L, et al. AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab. 2010;298(4):E751–E760. doi: 10.1152/ajpendo.00745.2009
  17. Luo Z, Tian M, Yang G, et al. Hypoxia signaling in human health and diseases: implications and prospects for therapeutics. Signal Transduct Target Ther. 2022;7(1):218. doi: 10.1038/s41392-022-01080-1 EDN: WSHTZP
  18. Uzun AB, Iliescu MG, Stanciu LE, et al. Effectiveness of Intermittent Hypoxia-Hyperoxia Therapy in Different Pathologies with Possible Metabolic Implications. Metabolites. 2023;13(2):181. doi: 10.3390/metabo13020181 EDN: ZWMOJW
  19. Tobin B, Costalat G, Renshaw GMC. Intermittent not continuous hypoxia provoked haematological adaptations in healthy seniors: hypoxic pattern may hold the key. Eur J Appl Physiol. 2020;120(3):707–718. doi: 10.1007/s00421-020-04310-y EDN: NNYVVS
  20. Corrado C, Fontana S. Hypoxia and HIF Signaling: One Axis with Divergent Effects. Int J Mol Sci. 2020;21(16):5611. doi: 10.3390/ijms21165611 EDN: RYHJSZ
  21. Wahl P, Schmidt A, Demarees M, et al. Responses of angiogenic growth factors to exercise, to hypoxia and to exercise under hypoxic conditions. Int J Sports Med. 2013;34(2):95–100. doi: 10.1055/s-0032-1314815
  22. Serebrovskaya TV, Xi L. Intermittent hypoxia training as non-pharmacologic therapy for cardiovascular diseases: Practical analysis on methods and equipment. Exp Biol Med (Maywood). 2016;241(15):1708–1723. doi: 10.1177/1535370216657614 EDN: WSYEFB
  23. Bayer U, Likar R, Pinter G, et al. Intermittent hypoxic-hyperoxic training on cognitive performance in geriatric patients. Alzheimers Dement (N Y). 2017;3(1):114–122. doi: 10.1016/j.trci.2017.01.002 EDN: YVDPHJ
  24. Bowser JL, Lee JW, Yuan X, Eltzschig HK. The hypoxia-adenosine link during inflammation. J Appl Physiol (1985). 2017;123(5):1303–1320. doi: 10.1152/japplphysiol.00101.2017
  25. Timon R, Martínez-Guardado I, Camacho-Cardeñosa A, et al. Effect of intermittent hypoxic conditioning on inflammatory biomarkers in older adults. Exp Gerontol. 2021;152:111478. doi: 10.1016/j.exger.2021.111478 EDN: RZAIWQ
  26. Sazontova TG, Bolotova AV, Bedareva IV, Kostina NV, Arkhipenko YV. Adaptation to intermittent hypoxia/hyperoxia enhances efficiency of exercise training. In: Xi L, Serebrovskaya TV, editors. Intermittent hypoxia and human diseases. London: Springer London; 2012. P. 191–205.
  27. Bell EL, Klimova TA, Eisenbart J, Schumacker PT, Chandel NS. Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia. Mol Cell Biol. 2007;27(16):5737–5745. doi: 10.1128/MCB.02265-06
  28. Chandel NS, Schumacker PT. Cellular oxygen sensing by mitochondria: old questions, new insight. J Appl Physiol (1985). 2000;88(5):1880–1889. doi: 10.1152/jappl.2000.88.5.1880 EDN: LPLUHF
  29. Lukyanova LD, Kirova YuI. Effect of hypoxic preconditioning on free radical processes in tissues of rats with different resistance to hypoxia. Bulletin of Experimental Biology and Medicine. 2011;151(3):263–268. EDN: NSAHVF
  30. Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell. 2012;48(2):158–167. doi: 10.1016/j.molcel.2012.09.025
  31. Afina AB, Oleg SG, Alexander AB, et al. The Effects of Intermittent Hypoxic-Hyperoxic Exposures on Lipid Profile and Inflammation in Patients With Metabolic Syndrome. Front Cardiovasc Med. 2021;8:700826. doi: 10.3389/fcvm.2021.700826 EDN: CPYBXP
  32. Bondarenko NN, Khomutov EV, Ryapolova TL, et al. Molecular and cellular mechanisms of hypoxic response. Ul'yanovskiy mediko-biologicheskiy zhurnal. 2023;2:6–29. doi: 10.34014/2227-1848-2023-2-6-29 EDN: KDWYWV
  33. Luo Y, Chen Q, Zou J, et al. Chronic Intermittent Hypoxia Exposure Alternative to Exercise Alleviates High-Fat-Diet-Induced Obesity and Fatty Liver. Int J Mol Sci. 2022;23(9):5209. doi: 10.3390/ijms23095209 EDN: ENIIJY
  34. Eltzschig HK. Extracellular adenosine signaling in molecular medicine. J Mol Med (Berl). 2013;91(2):141–146. doi: 10.1007/s00109-013-0999-z EDN: HDPXPW
  35. Eltzschig HK, Weissmüller T, Mager A, Eckle T. Nucleotide metabolism and cell-cell interactions. Methods Mol Biol. 2006;341:73–87. doi: 10.1385/1-59745-113-4
  36. Heß V, Kasim M, Mathia S, et al. Episodic Hypoxia Promotes Defence Against Cellular Stress. Cell Physiol Biochem. 2019;52(5):1075–1091. doi: 10.33594/000000073.
  37. Lukyanova LD, Germanova EL, Kopaladze RA. Development of resistance of an organism under various conditions of hypoxic preconditioning: role of the hypoxic period and reoxygenation. Bulletin of Experimental Biology and Medicine. 2009;147(4):380–384. EDN: MUEFSZ
  38. Arkhipenko YV, Sazontova TG, Zhukova AG. Adaptation to periodic hypoxia and hyperoxia improves resistance of membrane structures in heart, liver, and brain. Bull Exp Biol Med. 2005;140(3):278–281. doi: 10.1007/s10517-005-0466-0 EDN: LJKTNR
  39. Townsend K, Tseng YH. Brown adipose tissue: Recent insights into development, metabolic function and therapeutic potential. Adipocyte. 2012;1(1):13–24. doi: 10.4161/adip.18951
  40. Duennwald T, Gatterer H, Groop PH, Burtscher M, Bernardi L. Effects of a single bout of interval hypoxia on cardiorespiratory control and blood glucose in patients with type 2 diabetes. Diabetes Care. 2013;36(8):2183–2189. doi: 10.2337/dc12-2113 EDN: SQDPCZ
  41. Dale EA, Ben Mabrouk F, Mitchell GS. Unexpected benefits of intermittent hypoxia: enhanced respiratory and nonrespiratory motor function. Physiology (Bethesda). 2014;29(1):39–48. doi: 10.1152/physiol.00012.2013 EDN: YEIKNF
  42. Glazachev OS, Dudnik EN, Pozdnyakov YuM. Adaptation to intermittent hypoxia-hyperoxia in rehabilitation of patients with coronary artery disease. Humans and their health. 2014;(1):58–64. EDN: SNMMHR
  43. Behrendt T, Bielitzki R, Behrens M, Herold F, Schega L. Effects of Intermittent Hypoxia-Hyperoxia on Performance- and Health-Related Outcomes in Humans: A Systematic Review. Sports Med Open. 2022;8(1):70. doi: 10.1186/s40798-022-00450-x EDN: KPLFZV
  44. Ignatenko GA, Mukhi IV, Gavrilyak VG. Hypoxia hyperoxitherapy in the treatment of patients with comorbid cardiac pathology. Universiti Clinic. 2019;(1(30)):5–10. EDN: EZEUZZ
  45. Glazachev OS, Dudnik EN, Platonenko AV, Spirina GK. Gipoksicheskie trenirovki v kardioreabilitatsii: korrektsiya metabolicheskikh i kardiovaskulyarnykh faktorov riska. CardioSomatics. 2011;2(1-1):23–24. doi: 10.26442/CS45113 EDN: TRKQUR
  46. Kryzhanovskaya SYu, Dudnik EN, Zapara MA, Samarzeva VG, Glazachev OS. Hypoxic conditioning procedures do not lead to excessive activation of oxidative stress in healthy subjects. Russian journal of physiology. 2019;105(1):89–99. doi: 10.1134/S0869813919010047 EDN: VUBUFJ
  47. Glazachev OS, Kryzhanovskaya SYu, Zapara MA, et al. Safety and Efficacy of Intermittent Hypoxia Conditioning as a New Rehabilitation/Secondary Prevention Strategy for Patients with CardiovascularDiseases: A Systematic Review and Meta-analysis. Current Cardiology Reviews. 2021;17(6):e051121193317. doi: 10.2174/1573403X17666210514005235 EDN: CMJNPI
  48. Schega L, Peter B, Brigadski T, et al. Effect of intermittent normobaric hypoxia on aerobic capacity and cognitive function in older people. J Sci Med Sport. 2016;19(11):941–945. doi: 10.1016/j.jsams.2016.02.012 EDN: XTFEWL
  49. Behrendt T, Bielitzki R, Behrens M, Glazachev OS, Schega L. Effects of Intermittent Hypoxia-Hyperoxia Exposure Prior to Aerobic Cycling Exercise on Physical and Cognitive Performance in Geriatric Patients-A Randomized Controlled Trial. Front Physiol. 202226;13:899096. doi: 10.3389/fphys.2022.899096 EDN: SZSRZN
  50. van Hulten V, van Meijel RLJ, Goossens GH. The impact of hypoxia exposure on glucose homeostasis in metabolically compromised humans: A systematic review. Rev Endocr Metab Disord. 2021;22(2):471–483. doi: 10.1007/s11154-021-09654-0 EDN: FOIAMH
  51. Burtscher J, Maglione V, Di Pardo A, et al. A Rationale for Hypoxic and Chemical Conditioning in Huntington's Disease. Int J Mol Sci. 2021;22(2):582. doi: 10.3390/ijms22020582
  52. Burtscher J, Syed MMK, Lashuel HA, Millet GP. Hypoxia Conditioning as a Promising Therapeutic Target in Parkinson's Disease? Mov Disord. 2021;36(4):857–861. doi: 10.1002/mds.28544 EDN: ARNRIL
  53. Burtscher J, Mallet RT, Burtscher M, Millet GP. Hypoxia and brain aging: Neurodegeneration or neuroprotection? Ageing Res Rev. 2021;68:101343. doi: 10.1016/j.arr.2021.101343 EDN: NVFFAP
  54. Camacho-Cardenosa A, Camacho-Cardenosa M, Brooks D, et al. Effects training in hypoxia on cardiometabolic parameters in obese people: A systematic review of randomized controlled trial. Aten Primaria. 2019;51(7):397–405. doi: 10.1016/j.aprim.2018.03.011
  55. Saeed O, Bhatia V, Formica P, et al. Improved exercise performance and skeletal muscle strength after simulated altitude exposure: a novel approach for patients with chronic heart failure. J Card Fail. 2012;18(5):387–391. doi: 10.1016/j.cardfail.2012.02.003
  56. Lyamina NP, Lyamina SV, Senchiknin VN, et al. Normobaric hypoxia conditioning reduces blood pressure and normalizes nitric oxide synthesis in patients with arterial hypertension. J Hypertens. 2011;29(11):2265–2272. doi: 10.1097/HJH.0b013e32834b5846. EDN: PECQPR
  57. Ignatenko GA, Mukhin IV, Gavrilyak VG, Chebotareva EN, Dzyuban AS. Ischemic preconditioning and the potential of hypoxia-hyperoxytherapy. Vestnik neotlozhnoi i vosstanovitel'noi khirurgii. 2018;3(3):249–255. EDN: PHMRBW
  58. Serebrovska TV, Portnychenko AG, Portnichenko VI, et al. Effects of intermittent hypoxia training on leukocyte pyruvate dehydrogenase kinase 1 (PDK-1) mRNA expression and blood insulin level in prediabetes patients. Eur J Appl Physiol. 2019;119(3):813–823. doi: 10.1007/s00421-019-04072-2 EDN: WYTUSV
  59. Fuller NR, Courtney R. A case of remission from pre-diabetes following intermittent hypoxic training. Obes Res Clin Pract. 2016;10(4):487–491. doi: 10.1016/j.orcp.2016.05.008 EDN: XZHEMX
  60. Brinkmann C, Metten A, Scriba P, et al. Hypoxia and Hyperoxia Affect Serum Angiogenic Regulators in T2DM Men during Cycling. Int J Sports Med. 2017;38(2):92–98. doi: 10.1055/s-0042-116823 EDN: YCUGLJ

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2025 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 64546 от 22.01.2016.